{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-001", "question": "A 45-year-old woman with a history of recurrent calcium oxalate kidney stones presents with acute pancreatitis. Lipase is 1200 U/L, calcium 11.8 mg/dL, PTH 85 pg/mL (normal 10-65). She is not on lithium or thiazides. A pancreatic protocol CT shows diffuse gland enlargement but no necrosis or ductal dilation. The most likely underlying etiology of her pancreatitis is:", "options": ["Primary hyperparathyroidism due to parathyroid adenoma", "Autoimmune pancreatitis (IgG4-related disease)", "Hereditary pancreatitis due to PRSS1 mutation", "Hypertriglyceridemia-induced pancreatitis", "Pancreatitis secondary to a gastrinoma (Zollinger-Ellison syndrome)"], "answer": "A", "answer_index": 0, "explanation": "The triad of hypercalcemia, elevated PTH, and recurrent calcium oxalate stones is classic for primary hyperparathyroidism. Hypercalcemia is a known, though uncommon, cause of pancreatitis. The elevated PTH confirms primary hyperparathyroidism, not secondary causes. While hypertriglyceridemia (D) can cause pancreatitis, it doesn't explain the hypercalcemia and elevated PTH. Gastrinoma (E) is associated with ulcers and diarrhea, not typically hypercalcemia and stones.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "abms_specialty": "Endocrine", "abms_source": "topics_mapped", "source_label_raw": "endocrinology", "source_quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "source_question_id": "20251205T082731900Z_deepseek-v3.2_seed123-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T082731900Z_deepseek-v3.2_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T082731900Z_deepseek-v3.2_seed123.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-002", "question": "A 52-year-old man with alcohol-related cirrhosis presents with acute upper GI bleeding. During emergent endoscopy, active spurting is seen from a large duodenal ulcer in the posterior bulb. After epinephrine injection and placement of two through-the-scope clips, bleeding continues. The following day, he develops fever and severe abdominal pain. CT shows retroperitoneal air and fluid tracking along the right psoas muscle. What is the most appropriate management?", "options": ["Angiographic embolization of the gastroduodenal artery", "Emergency laparotomy with duodenal diversion", "Percutaneous drainage of the retroperitoneal collection", "Repeat endoscopy with over-the-scope clip placement", "IV antibiotics and serial abdominal exams"], "answer": "B", "answer_index": 1, "explanation": "This scenario describes a posterior duodenal ulcer perforation into the retroperitoneum following endoscopic intervention. Given the ongoing bleeding and established contamination, definitive surgical management with duodenal diversion (e.g., Graham patch closure with gastrodujunostomy) is required. Angioembolization would address bleeding but not the perforation. Percutaneous drainage cannot control the duodenal leak. Repeat endoscopy is contraindicated with known perforation. Antibiotics alone would lead to uncontrolled sepsis.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Gastrointestinal", "abms_specialty": "Gastrointestinal", "abms_source": "target_topic", "source_label_raw": "Gastrointestinal", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed130-016", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed130.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-003", "question": "A 48-year-old woman with a history of systemic lupus erythematosus (SLE) on hydroxychloroquine and low-dose prednisone presents with 3 weeks of progressive dyspnea on exertion and dry cough. High-resolution CT shows diffuse ground-glass opacities with superimposed fine reticulation and subpleural sparing. Bronchoalveolar lavage reveals lymphocytic predominance (65%) with CD4:CD8 ratio of 0.8. Pulmonary function tests show a restrictive pattern with severely reduced DLCO (38% predicted). Which of the following is the most appropriate next step in management?", "options": ["Initiate high-dose intravenous methylprednisolone followed by oral prednisone 1 mg/kg/day", "Add mycophenolate mofetil to current immunosuppression", "Discontinue hydroxychloroquine and observe for 4 weeks", "Perform surgical lung biopsy to confirm usual interstitial pneumonia pattern", "Start rituximab therapy without additional testing"], "answer": "B", "answer_index": 1, "explanation": "The presentation is classic for lymphocytic interstitial pneumonia (LIP) associated with SLE, characterized by ground-glass opacities with reticulation, lymphocytic BAL, and low CD4:CD8 ratio. LIP in connective tissue disease typically requires more aggressive immunosuppression beyond steroids alone. Mycophenolate mofetil is the preferred steroid-sparing agent for SLE-associated interstitial lung disease with this pattern. High-dose steroids alone (A) are insufficient for progressive LIP. Hydroxychloroquine cessation (C) is unlikely to reverse established ILD. Surgical biopsy (D) is unnecessary with characteristic HRCT and BAL findings. Rituximab (E) is reserved for refractory cases after conventional immunosuppression fails.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pulmonary", "abms_specialty": "Pulmonary", "abms_source": "topics_mapped", "source_label_raw": "pulmonology", "source_quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "source_question_id": "20251205T082731900Z_deepseek-v3.2_seed124-001", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T082731900Z_deepseek-v3.2_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T082731900Z_deepseek-v3.2_seed124.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-004", "question": "A 35-year-old woman with tuberous sclerosis complex develops rapidly progressive renal insufficiency. Imaging shows massively enlarged kidneys with innumerable angiomyolipomas, the largest measuring 8 cm. What is the most appropriate intervention to preserve renal function?", "options": ["Selective arterial embolization of the dominant tumors", "Initiation of everolimus therapy", "Bilateral nephrectomy with dialysis initiation", "Cryoablation of the largest angiomyolipomas", "Radical nephrectomy of the more affected kidney"], "answer": "B", "answer_index": 1, "explanation": "In TSC with diffuse angiomyolipomatosis causing renal failure, everolimus (an mTOR inhibitor) is first-line therapy as it targets the underlying pathophysiology, can reduce tumor size by over 50%, and preserves renal function better than procedural interventions. Embolization or ablation would be impractical for innumerable tumors and could accelerate renal decline. Nephrectomy should be avoided unless absolutely necessary for hemorrhage control. Everolimus addresses the systemic nature of TSC renal involvement.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Nephrology", "abms_specialty": "Nephrology", "abms_source": "target_topic", "source_label_raw": "Nephrology", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed130-017", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed130.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-005", "question": "A 62-year-old man with essential thrombocythemia (JAK2 V617F-positive) on hydroxyurea presents with acute onset of severe headache and right hemiparesis. CT head shows left middle cerebral artery territory infarction. Platelet count is 450,000/μL. MRI brain with contrast reveals multiple small enhancing lesions in both cerebral hemispheres. Transthoracic echocardiogram shows no vegetations. Blood cultures are negative. Which of the following is the most likely underlying mechanism for his stroke?", "options": ["Nonbacterial thrombotic endocarditis from hypercoagulable state", "Leukoencephalopathy from hydroxyurea toxicity", "Transformation to acute myeloid leukemia with CNS involvement", "Cerebral vasculitis secondary to JAK2 mutation", "Paradoxical embolism through patent foramen ovale"], "answer": "A", "answer_index": 0, "explanation": "Myeloproliferative neoplasms, particularly essential thrombocythemia, can cause nonbacterial thrombotic endocarditis (NBTE) with sterile vegetations that embolize to cerebral arteries. The multiple enhancing brain lesions represent septic emboli analogs from NBTE. Hydroxyurea leukoencephalopathy causes symmetric white matter changes without enhancing lesions. AML transformation would show blasts in blood or marrow. Cerebral vasculitis is not associated with JAK2 mutations. Paradoxical embolism would not explain multiple enhancing lesions without a venous source.", "generator_model": "deepseek-v3.2", "seed": 133, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Hematology", "abms_specialty": "Hematology", "abms_source": "target_topic", "source_label_raw": "Hematology", "source_quiz_id": "20251219T221819110Z_deepseek-v3.2_seed133", "source_question_id": "20251219T221819110Z_deepseek-v3.2_seed133-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251219T221819110Z_deepseek-v3.2_seed133", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251219T221819110Z_deepseek-v3.2_seed133.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-006", "question": "A 28-year-old woman develops recurrent sinopulmonary infections and bronchiectasis. Workup reveals absent IgA, markedly reduced IgG and IgM, and absent B cells on flow cytometry. Genetic testing identifies a mutation in the λ5 surrogate light chain gene. Which specific immunological abnormality explains her infection pattern?", "options": ["Failure of heavy chain rearrangement in pre-B cells", "Defective VDJ recombination due to RAG deficiency", "Absence of the pre-B cell receptor complex signaling", "Mutation in the BLNK adapter protein preventing PLCγ activation", "Loss of BTK enzyme function disrupting B cell maturation"], "answer": "C", "answer_index": 2, "explanation": "The λ5 gene encodes part of the surrogate light chain critical for pre-B cell receptor formation. Without functional pre-BCR signaling, B cells fail to proliferate and mature at the pre-B cell stage, causing the arrested development seen here. This is distinct from Bruton's tyrosine kinase deficiency (which affects later signaling) or RAG deficiencies (which impair initial recombination). The specific λ5 mutation explains the profound B cell deficiency and hypogammaglobulinemia.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Immunology", "abms_specialty": "Immunology", "abms_source": "target_topic", "source_label_raw": "Immunology", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed130-008", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed130.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-007", "question": "A 44-year-old woman presents with 8 months of progressive proximal muscle weakness, heliotrope rash, and Gottron's papules. Muscle biopsy shows perfascicular atrophy and MAC deposition on capillaries. She tests positive for anti-MDA5 antibodies. Which of the following complications carries the highest immediate mortality risk?", "options": ["Aspiration pneumonia", "Cardiac conduction abnormalities", "Rapidly progressive interstitial lung disease", "Malignancy-associated deterioration", "Calcinosis universalis"], "answer": "C", "answer_index": 2, "explanation": "Anti-MDA5 antibody-positive dermatomyositis is strongly associated with rapidly progressive interstitial lung disease (RP-ILD), which has mortality exceeding 50% within 6 months despite treatment. This subtype shows characteristic skin findings but often minimal muscle involvement, with MAC deposition on capillaries. While aspiration (A) and cardiac issues (B) occur in myositis, RP-ILD is the most lethal complication in anti-MDA5 patients. Malignancy risk (D) is lower with anti-MDA5 than with anti-TIF1γ. Calcinosis (E) is chronic but not immediately life-threatening. Early recognition and aggressive immunosuppression for RP-ILD are critical in anti-MDA5 dermatomyositis.", "generator_model": "deepseek-v3.2", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Rheumatology/Musculoskeletal", "abms_specialty": "Rheumatology/Musculoskeletal", "abms_source": "topics_mapped", "source_label_raw": "rheumatology", "source_quiz_id": "20251205T082731900Z_deepseek-v3.2_seed124", "source_question_id": "20251205T082731900Z_deepseek-v3.2_seed124-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251205T082731900Z_deepseek-v3.2_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251205T082731900Z_deepseek-v3.2_seed124.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-008", "question": "A 30-year-old missionary presents with a slowly enlarging scalp lesion after returning from Bolivia. biopsy demonstrates lobulated granulomatous inflammation with rare 5-7 μm budding yeast. Culture on brain-heart infusion agar at 25°C shows cream-colored colonies that convert to yeast form at 37°C. What is the most appropriate antifungal therapy?", "options": ["Itraconazole for 6-12 months", "Amphotericin B lipid complex followed by itraconazole", "Voriconazole indefinitely", "Posaconazole with therapeutic drug monitoring", "Fluconazole for 3-6 months"], "answer": "A", "answer_index": 0, "explanation": "The presentation describes cutaneous granulomas caused by Paracoccidioides brasiliensis, endemic to Latin America. Itraconazole is first-line for non-severe disease, with 6-12 months treatment typically achieving cure. Amphotericin B is reserved for severe disseminated disease. Voriconazole has variable activity against Paracoccidioides. Fluconazole is less effective due to higher relapse rates. The dimorphic growth pattern and geographic history are classic for this infection.", "generator_model": "deepseek-v3.2", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Infectious Disease", "abms_specialty": "Infectious Disease", "abms_source": "target_topic", "source_label_raw": "Infectious Disease", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed130", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed130-019", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed130.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-009", "question": "A 45‑year‑old woman with metastatic HER2‑positive breast cancer (bone, liver) on first‑line therapy with trastuzumab, pertuzumab, and docetaxel achieves a partial response after 6 cycles. Maintenance trastuzumab/pertuzumab is continued. One year later, surveillance CT shows a new 2 cm pancreatic tail mass, biopsy‑proven adenocarcinoma consistent with breast primary (ER‑/PR‑/HER2 3+ by IHC). Next‑generation sequencing of the pancreatic lesion reveals an activating mutation in PIK3CA (H1047R) and no HER2 amplification by NGS (though IHC remains 3+). She has never received a CDK4/6 inhibitor or everolimus. What is the most appropriate next systemic therapy?", "options": ["Continue trastuzumab/pertuzumab and add capecitabine", "Switch to trastuzumab deruxtecan (T‑DXd)", "Switch to lapatinib plus capecitabine", "Switch to everolimus plus exemestane", "Switch to alpelisib plus fulvestrant"], "answer": "B", "answer_index": 1, "explanation": "This represents HER2‑positive breast cancer with apparent HER2 discordance (IHC 3+ but no amplification by NGS) and acquired PIK3CA mutation. Trastuzumab deruxtecan (T‑DXd) is effective even in HER2‑low disease and has shown activity in HER2‑positive cancers resistant to trastuzumab/pertuzumab. Continuing dual HER2 blockade with chemotherapy is less likely to work given possible HER2‑negative clone emergence. Lapatinib/capecitabine is an older second‑line option but inferior to T‑DXd. Everolimus/exemestane or alpelisib/fulvestrant target hormone pathway/PIK3CA but are for HR‑positive disease; here the tumor is ER‑/PR‑.", "generator_model": "deepseek-v3.2", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Medical Oncology", "abms_specialty": "Medical Oncology", "abms_source": "target_topic", "source_label_raw": "Medical Oncology", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed131", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed131-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed131.jsonl"}
{"quiz_id": "ABMS20260101_deepseek-v3.2_p03", "question_id": "ABMS20260101_deepseek-v3.2_p03-010", "question": "A 32-year-old woman with common variable immunodeficiency (CVID) on monthly IVIG develops acute severe headache, photophobia, and neck stiffness 36 hours after her infusion. LP shows: opening pressure 28 cm H2O, WBC 2/μL, protein 40 mg/dL, glucose 60 mg/dL (serum 95 mg/dL). Gram stain and culture negative. MRI brain with contrast is normal. She has had two similar but milder episodes in the past 12 months, always within 48 hours of IVIG. Which intervention is most likely to prevent recurrence while maintaining adequate immune protection?", "options": ["Switch to subcutaneous immunoglobulin (SCIG) at the same monthly dose", "Pre‑infusion high‑dose corticosteroid (e.g., methylprednisolone 1 g IV)", "Change IVIG product to a sucrose‑free, low‑osmolality formulation", "Administer IVIG at a slower infusion rate (e.g., over 72 hours) with pre‑hydration", "Replace IVIG with prophylactic antibiotics and as‑needed plasma infusions"], "answer": "A", "answer_index": 0, "explanation": "This describes aseptic meningitis secondary to IVIG, a well‑known complication related to high peak IgG levels and cytokine release. Switching to SCIG provides steady‑state IgG levels without peaks, dramatically reducing meningitis risk while maintaining protection. Slower infusion or changing formulation may reduce but not eliminate risk in susceptible patients. Pre‑infusion steroids are not routinely effective and pose long‑term risks. Discontinuing immunoglobulin replacement in CVID would lead to serious infections despite antibiotics.", "generator_model": "deepseek-v3.2", "seed": 131, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Allergy/Immunology", "abms_specialty": "Allergy/Immunology", "abms_source": "target_topic", "source_label_raw": "Allergy / Immunology", "source_quiz_id": "20251216T183904770Z_deepseek-v3.2_seed131", "source_question_id": "20251216T183904770Z_deepseek-v3.2_seed131-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/deepseek-v3.2/20251216T183904770Z_deepseek-v3.2_seed131", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251216T183904770Z_deepseek-v3.2_seed131.jsonl"}
